Trial Profile
Effectiveness and tolerability of fludarabine and busulfan conditioning regimen in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary) ; Antithymocyte globulin; Busulfan
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 02 Nov 2015 New trial record